Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35 | 7 | 1 | 2 | 57 |
| Receivables | 14 | 24 | N/A | N/A | N/A |
| TOTAL | $49 | $31 | $1 | $2 | $57 |
| Non-Current Assets | |||||
| PPE Net | 360 | 337 | 281 | 281 | 206 |
| TOTAL | $360 | $337 | $281 | $281 | $206 |
| Total Assets | $409 | $368 | $283 | $283 | $263 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 349 | 502 | 358 | 551 | 444 |
| TOTAL | $349 | $502 | $358 | $551 | $444 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 32 | 36 | 31 | 0 | 0 |
| TOTAL | $32 | $36 | $31 | $N/A | $N/A |
| Total Liabilities | $380 | $538 | $389 | $551 | $444 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,264 | 6,496 | 6,796 | 13,700 | 13,100 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -1,497 | -1,262 | -1,166 | -950 | -228 |
| TOTAL | $28 | $-170 | $-106 | $-269 | $-181 |
| Total Liabilities And Equity | $409 | $368 | $283 | $283 | $263 |